health · HHS-NIH11
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-27-051
Deadline
April 17, 2029
GRANTQUICK SUMMARYPlain-English Overview
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access. National Institutes of Health. The National Institute on Drug Abuse seeks to advance its mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population... Funding amounts not specified.
Who Should Apply
Independent school districts, Federally Recognized Native American Tribal Governments, State governments, Private universities/colleges, Nonprofits (501c3) (+8 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
National Institute of Drug Abuse (NIDA) nidagmbemail@nida.nih.gov
nidagmbemail@nida.nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov